BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
39.635 EUR
+1.23 (+3.22%)
We assign a fundamental rating of 6 out of 10 to 1BMY. 1BMY was compared to 54 industry peers in the Pharmaceuticals industry. 1BMY has an average financial health and profitability rating. 1BMY scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally 1BMY also has an excellent dividend rating. These ratings would make 1BMY suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
1BMY had positive earnings in the past year.
In the past year 1BMY had a positive cash flow from operations.
In multiple years 1BMY reported negative net income over the last 5 years.
Each year in the past 5 years 1BMY had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.23%, 1BMY is in line with its industry, outperforming 56.36% of the companies in the same industry.
The Return On Equity of 1BMY (32.55%) is better than 80.00% of its industry peers.
1BMY's Return On Invested Capital of 17.49% is amongst the best of the industry. 1BMY outperforms 81.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1BMY is below the industry average of 13.79%.
The 3 year average ROIC (11.67%) for 1BMY is below the current ROIC(17.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.49% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
Looking at the Profit Margin, with a value of 12.57%, 1BMY is in line with its industry, outperforming 52.73% of the companies in the same industry.
Looking at the Operating Margin, with a value of 33.51%, 1BMY belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
1BMY's Operating Margin has declined in the last couple of years.
The Gross Margin of 1BMY (73.15%) is comparable to the rest of the industry.
1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
1BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1BMY has been reduced compared to 1 year ago.
The number of shares outstanding for 1BMY has been reduced compared to 5 years ago.
1BMY has a worse debt/assets ratio than last year.
2.2 Solvency
1BMY has an Altman-Z score of 2.10. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.10, 1BMY is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of 1BMY is 3.20, which is a good value as it means it would take 1BMY, 3.20 years of fcf income to pay off all of its debts.
1BMY has a better Debt to FCF ratio (3.20) than 61.82% of its industry peers.
A Debt/Equity ratio of 2.41 is on the high side and indicates that 1BMY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.41, 1BMY is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.1 |
ROIC/WACC2.11
WACC8.3%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, 1BMY is not doing good in the industry: 65.45% of the companies in the same industry are doing better.
A Quick Ratio of 1.17 indicates that 1BMY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, 1BMY is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 460.68% over the past year.
1BMY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.57% yearly.
Looking at the last year, 1BMY shows a small growth in Revenue. The Revenue has grown by 1.26% in the last year.
Measured over the past years, 1BMY shows a quite strong growth in Revenue. The Revenue has been growing by 13.06% on average per year.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
Based on estimates for the next years, 1BMY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.26% on average per year.
1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.97% yearly.
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.04 indicates a rather cheap valuation of 1BMY.
Based on the Price/Earnings ratio, 1BMY is valued cheaply inside the industry as 94.55% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.61, 1BMY is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.57, the valuation of 1BMY can be described as very cheap.
Based on the Price/Forward Earnings ratio, 1BMY is valued cheaper than 90.91% of the companies in the same industry.
1BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.01, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 92.73% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than 1BMY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.14 | ||
| EV/EBITDA | 5.97 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1BMY's earnings are expected to grow with 73.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.22%
EPS Next 3Y73.98%
5. Dividend
5.1 Amount
1BMY has a Yearly Dividend Yield of 4.77%, which is a nice return.
Compared to an average industry Dividend Yield of 1.85, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
5.2 History
The dividend of 1BMY is nicely growing with an annual growth rate of 11.67%!
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
82.81% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
The dividend of 1BMY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.81%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
BIT:1BMY (11/20/2025, 7:00:00 PM)
39.635
+1.23 (+3.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners81.74%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap80.69B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts67.65
Price Target45.28 (14.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)2.04%
PT rev (3m)-2%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.19%
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 | ||
| P/S | 1.96 | ||
| P/FCF | 6.14 | ||
| P/OCF | 5.65 | ||
| P/B | 5.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.97 |
EPS(TTM)5.63
EY14.2%
EPS(NY)5.23
Fwd EY13.2%
FCF(TTM)6.45
FCFY16.29%
OCF(TTM)7.01
OCFY17.69%
SpS20.26
BVpS7.83
TBVpS-9.98
PEG (NY)0.01
PEG (5Y)N/A
Graham Number31.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.49% | ||
| ROICexc | 22.99% | ||
| ROICexgc | 117.18% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.1 |
F-Score6
WACC8.3%
ROIC/WACC2.11
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year262.1%
EBIT Next 3Y50.55%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
How sustainable is the dividend of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.